MedTrace Logo

Power Strength Training in Type 2 Diabetic Mellitus Older Adults

NCT04332302 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2020-10-19

No results posted yet for this study

Summary

Diabetes is a disease with a high impact in the population older than 65 years old. Some indications suggest that diabetes in the old age aggravate the negative effects of ageing, as the loss of muscle mass and strength, bringing the patients to a situation of vulnerability and elevated risk of disability and death known as "frailty syndrome". Recently, scientists have observed that if older population train with musculation machines emphasising the muscular power, it is possible to have an impact on a disminution of frailty and restoring the physical functionality. This project deeps in the physiological and molecular mechanisms that underlie to improvements in the frail diabetic patients.

Conditions

  • Diabetes Mellitus, Type 2
  • Frailty

Interventions

OTHER

Power resistance training

Participants will take part in an intervention of 12 weeks duration in which they will train with musculation machines.

Sponsors & Collaborators

  • Spanish Society of Diabetes

    collaborator UNKNOWN

  • University of Castilla-La Mancha

    collaborator OTHER

  • Castilla-La Mancha Health Service

    collaborator OTHER

  • Technical University of Madrid

    lead OTHER

Principal Investigators

  • Amelia Guadalupe Grau, PhD · Technical University of Madrid

  • Carmen Ramírez Castillejo, PhD · Technical University of Madrid

  • Marcela González Gross, Professor · Technical University of Madrid

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2020-05-15
Completion
2021-12-21

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04332302 on ClinicalTrials.gov